Matthew Meyerson

Broad Institute — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

223h-index302.8kcitations1.9kworks0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(530), Lung Cancer Treatments and Mutations(251), Pancreatic and Hepatic Oncology Research(234), RNA modifications and cancer(177), Colorectal Cancer Treatments and Studies(136)

Publications1.7k total

Rapid loss of viability in acute myeloid leukemia cells upon telomerase inactivation
Blood Advances·2025Open Access
Publisher Correction: Mutant p53 protein accumulation is selectively targetable by proximity-inducing drugs
Nature Chemical Biology·2025Open Access
<i>MYC</i> amplification and MYC protein expression are poor prognostic markers in pediatric and young adult osteosarcoma
Cancer·2025· 2 cited
Mutant p53 protein accumulation is selectively targetable by proximity-inducing drugs
Nature Chemical Biology·2025· 5 citedOpen Access
DNAR-13. Uncovering novel mediators of radiation sensitivity in glioblastoma using functional genomic screening
Neuro-Oncology·2025
Germline Variants as Risk Factors for Early-Onset Lung Adenocarcinoma
Journal of Thoracic Oncology·2025· 1 cited
Abstract B046: Dimerization of SLFN12 by the PDE3A-SLFN12 complex is required for velcrin-induced toxicity in cancer cells
Molecular Cancer Therapeutics·2025
Sevabertinib, a Reversible HER2 Inhibitor with Activity in Lung Cancer
Cancer Discovery·2025· 3 citedOpen Access
Characterization of tumor-associated microbiome in multifocal small intestinal neuroendocrine tumors (SI-NETs)
ESMO Gastrointestinal Oncology·2025Open Access
Lineage rewiring in lung adenocarcinoma via HNF4α and NKX2-1 dynamics
Genes & Development·2025· 3 citedOpen Access
Abstract P4-03-20: Molecular characterization of estrogen receptor (ER)+/HER2- breast cancer unveils a biologically and clinically distinct entity with ERBB2 hemizygous deletion (ERBB2del)
Clinical Cancer Research·2025
High-Throughput Screening Tool to Identify Small Molecule Inhibitors of Telomerase
ACS Chemical Biology·2025Open Access
Abstract 6530: A comprehensive genomic analysis elucidates the microbial landscape of cancer
Cancer Research·2025· 1 cited
Abstract 2992: Uncovering metabolic dysregulation and therapeutic targets in aneuploid models of squamous cell carcinoma
Cancer Research·2025
Abstract 5610: BAY 2927088: a novel treatment option for patients with NSCLC with <i>HER2</i> mutations
Cancer Research·2025
PACT prevents aberrant activation of PKR by endogenous dsRNA without sequestration
Nature Communications·2025· 11 citedOpen Access
Amplified dosage of the NKX2-1 lineage transcription factor controls its oncogenic role in lung adenocarcinoma
Molecular Cell·2025· 6 cited
Author Correction: Genomic basis for RNA alterations in cancer
UNC Libraries·2025Open Access
Single-nucleus transcriptome profiling of enterochromaffin cells in SI-NET patients
Endocrine Abstracts·2025
Spatial transcriptomics of multifocal ileal neuroendocrine tumors reveals tumor heterogeneity based on tumor microenvironment and new biomarkers
Endocrine Abstracts·2025
page 1 of 88Next →

Frequent Co-authors

Gad Getz(33), Stacey Gabriel(23), Michael S. Lawrence(22), Todd R. Golub(15), Kristian Cibulskis(15), Carrie Sougnez(14), Levi A. Garraway(14), Wendy Winckler(13), Gordon Saksena(13), Scott L. Carter(12), Eric S. Lander(12), Rameen Beroukhim(12), Andrey Sivachenko(11), Andrew D. Cherniack(10), Robert C. Onofrio(9), Alex H. Ramos(9), Heidi Greulich(8), Kristin Ardlie(8), Daniel Auclair(8), Barbara A. Weir(7)